These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26919350)

  • 1. Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.
    Fernandez-Costa JM; Llamusi B; Bargiela A; Zulaica M; Alvarez-Abril MC; Perez-Alonso M; Lopez de Munain A; Lopez-Castel A; Artero R
    PLoS One; 2016; 11(2):e0150501. PubMed ID: 26919350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma microRNAs as biomarkers for myotonic dystrophy type 1.
    Perfetti A; Greco S; Bugiardini E; Cardani R; Gaia P; Gaetano C; Meola G; Martelli F
    Neuromuscul Disord; 2014 Jun; 24(6):509-15. PubMed ID: 24679513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1.
    Perfetti A; Greco S; Cardani R; Fossati B; Cuomo G; Valaperta R; Ambrogi F; Cortese A; Botta A; Mignarri A; Santoro M; Gaetano C; Costa E; Dotti MT; Silvestri G; Massa R; Meola G; Martelli F
    Sci Rep; 2016 Dec; 6():38174. PubMed ID: 27905532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.
    Fernandez-Costa JM; Garcia-Lopez A; Zuñiga S; Fernandez-Pedrosa V; Felipo-Benavent A; Mata M; Jaka O; Aiastui A; Hernandez-Torres F; Aguado B; Perez-Alonso M; Vilchez JJ; Lopez de Munain A; Artero RD
    Hum Mol Genet; 2013 Feb; 22(4):704-16. PubMed ID: 23139243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress.
    Koutsoulidou A; Kyriakides TC; Papadimas GK; Christou Y; Kararizou E; Papanicolaou EZ; Phylactou LA
    PLoS One; 2015; 10(4):e0125341. PubMed ID: 25915631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients.
    Gambardella S; Rinaldi F; Lepore SM; Viola A; Loro E; Angelini C; Vergani L; Novelli G; Botta A
    J Transl Med; 2010 May; 8():48. PubMed ID: 20487562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.
    Savić D; Rakocvic-Stojanovic V; Keckarevic D; Culjkovic B; Stojkovic O; Mladenovic J; Todorovic S; Apostolski S; Romac S
    Hum Mutat; 2002 Feb; 19(2):131-9. PubMed ID: 11793472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress.
    Koutsoulidou A; Photiades M; Kyriakides TC; Georgiou K; Prokopi M; Kapnisis K; Lusakowska A; Nearchou M; Christou Y; Papadimas GK; Anayiotos A; Kyriakou K; Kararizou E; Zamba Papanicolaou E; Phylactou LA
    Hum Mol Genet; 2017 Sep; 26(17):3285-3302. PubMed ID: 28637233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miRNAs as biomarkers for the rare types of muscular dystrophy.
    Koutsoulidou A; Koutalianos D; Georgiou K; Kakouri AC; Oulas A; Tomazou M; Kyriakides TC; Roos A; Papadimas GK; Papadopoulos C; Kararizou E; Spyrou GM; Zamba Papanicolaou E; Lochmüller H; Phylactou LA
    Neuromuscul Disord; 2022 Apr; 32(4):332-346. PubMed ID: 35393236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.
    Mazzoli M; Ariatti A; Garuti G; Agnoletto V; Fantini R; Marchioni A; Galassi G
    Acta Neurol Belg; 2021 Feb; 121(1):133-142. PubMed ID: 32651874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection for trinucleotide repeats in myotonic dystrophy type 1].
    Li Y; Da YW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):16-8. PubMed ID: 22311484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory failure in a mouse model of myotonic dystrophy does not correlate with the CTG repeat length.
    Panaite PA; Kuntzer T; Gourdon G; Barakat-Walter I
    Respir Physiol Neurobiol; 2013 Oct; 189(1):22-6. PubMed ID: 23811192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Diagnosis of Myotonic Dystrophy.
    Chakraborty S; Vatta M; Bachinski LL; Krahe R; Dlouhy S; Bai S
    Curr Protoc Hum Genet; 2016 Oct; 91():9.29.1-9.29.19. PubMed ID: 27727437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients.
    Braida C; Stefanatos RK; Adam B; Mahajan N; Smeets HJ; Niel F; Goizet C; Arveiler B; Koenig M; Lagier-Tourenne C; Mandel JL; Faber CG; de Die-Smulders CE; Spaans F; Monckton DG
    Hum Mol Genet; 2010 Apr; 19(8):1399-412. PubMed ID: 20080938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved method for molecular diagnosis of myotonic dystrophy type 1 (DM1).
    Erginel-Unaltuna N; Akbas F
    J Clin Lab Anal; 2004; 18(1):50-4. PubMed ID: 14730559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.
    Cappella M; Perfetti A; Cardinali B; Garcia-Manteiga JM; Carrara M; Provenzano C; Fuschi P; Cardani R; Renna LV; Meola G; Falcone G; Martelli F
    Cell Death Dis; 2018 Jun; 9(7):729. PubMed ID: 29955039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).
    Rossi S; Silvestri G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.